ARTICLE | Company News
Epirus, Ranbaxy sales and marketing update
December 8, 2014 8:00 AM UTC
The companies launched Infimab infliximab, a generic of autoimmune drug Remicade infliximab, in India. The partners declined to disclose the price of the generic. Johnson & Johnson Inc. (NYSE:JNJ, ...